The future of dermal toxicity testing lies in the continued development of alternative testing methods that reduce reliance on animal models while providing reliable and accurate data. Innovations in biotechnology and computational modeling will likely lead to more sophisticated and ethically sound testing approaches. As regulatory frameworks evolve, there will be an increased emphasis on integrating new technologies to improve the safety assessment of chemicals and products.
